JOURNAL OF POLYMER SCIENCE: PART A: POLYMER CHEMISTRY DOI 10.1002/POLA
ethylhexyl)oxy]-1,4-dioxaspiro[4.5]decane was obtained as
crude product. To a stirred solution of this crudeꢂ product in
acetic acid (5 mL) under argon was stirred at 50 C for 12 h.
After being poured the reaction mixture cautiously into satu-
rated aqueous sodium bicarbonate solution (50 mL), the
reaction mixture was diluted with ethylacetate (100 mL),
washed with distilled water (3 ꢃ 100 mL), and dried
(MgSO4). After removing the solvent under reduced pressure,
the residue was purified by flash chromatography (40 ꢃ 120
mm column, SiO2, EtOAc/hexane, 1:10) to give 0.35 g (5%)
of compound 7 as a colorless oil; Rf ¼ 0.2 (SiO2, EtOAc/hex-
ane, 1:10); 1H NMR (300 MHz, CDCl3) d 3.68–3.59 (m, 1H),
3.40–3.29 (m, 2H), 2.65–2.48 (m, 2H), 2.30–2.16 (m, 2H),
2.16–2.00 (m, 2H), 1.96–1.59 (m, 2H), 1.56–1.44 (m, 1H),
1.42–1.16 (m, 8H), 0.94–0.78 (m, 6H); 13C NMR (75 MHz,
CDCl3) d 211.9, 72.9, 71.4, 40.2, 37.4, 30.9, 30.8, 30.7, 29.4,
24.2, 23.3, 14.3, 11.4; HRMS, m/e calcd for C14H26O2
226.1933, measured 226.1931.
8.09 (dd, 2H, J ¼ 4.95, 3.84 Hz), 7.39 (dd, 2H, J ¼ 6.31, 5.22
Hz), 7.33 (s, 2H), 7.15 (dd, 2H, J ¼ 8.79, 5.22 Hz), 2.12–1.98
(m, 4H), 1.88–1.70 (m, 6H); 13C NMR (75 MHz, CDCl3) d
157.9, 139.1, 128.8, 128.4, 128.3, 128.2, 127.0, 108.2, 33.6,
26.2, 25.4; HRMS, m/e calcd for C20H18N2S2 350.0911, found
350.0914.
Synthesis of 4,7-Di(20-bromothien-50-yl)-2H-
benzimidazole-2-spirocyclohexane (11)
To a stirred solution of 4,7-di(thien-20-yl)-2H-benzimidazole-
2-spirocyclohexane (500 mg, 1.43 mmol) (10) in CHCl3 (12
mL) protected from light under argon was added NBS (508
mg, 2.85 mmol). After being stirred at room temperature for
3 h, the reaction mixture was diluted with CHCl3 (100 mL),
washed with saline (3 ꢃ 100 mL), and dried (MgSO4). After
removing the solvent under reduced pressure, the residue
was purified by flash chromatography (40 ꢃ 150 mm col-
umn, SiO2, CH2Cl2/hexane, 1:1) to give 1.18 g (83%) of com-
pound 11 as a red solid; Rf ¼ 0.6 (SiO2, CH2Cl2/hexane, 1:1);
1H NMR (300 MHz, CDCl3) d 7.71 (d, 2H, J ¼ 3.85 Hz), 7.23
(s, 2H), 7.09 (d, 2H, J ¼ 4.12 Hz), 2.10–1.94 (m, 4H), 1.88–
1.77 (m, 2H), 1.76–1.64 (m, 4H); 13C NMR (75 MHz, CDCl3)
d 157.4, 140.2, 130.9, 128.2, 127.6, 127.5, 115.5, 108.7, 33.4,
26.0, 25.3; HRMS, m/e calcd for C20H16Br2N2S2 507.9101,
found 507.9109.
Synthesis of 4,7-Dibromo-40-[(2-ethylhexyl)oxy]-
2H-benzimidazole-2-spirocyclohexane (8)
A solution of 3,6-dibromo-1,2-benzenediamine (464 mg, 1.74
mmol) (3) and 4-[(2-ethylhexyl)oxy]cyclohexanone (395 mg,
1.74 mmol) (7) in toluene (11 mL) under argon was stirred
ꢂ
at 120 C for 6 h. After removing the solvent under reduced
pressure, 4,7-dibromo-40-[(2-ethylhexyl)oxy]-2H-benzimida-
zole-2(3H)-spirocyclohexane was obtained as crude product.
To a stirred solution of this crude product in freshly distilled
CH2Cl2 (17 mL) at room temperature under argon was
added 85% activated manganese (IV) oxide (1.44 g, 14.11
mmol). After being stirred at room temperature for 1 h, the
reaction mixture was filtered, diluted with CH2Cl2 (100 mL),
washed with distilled water (3 ꢃ 100 mL), and dried
(MgSO4). After removing the solvent under reduced pressure,
the residue was purified by flash chromatography (40 ꢃ 150
mm column, SiO2, EtOAc/hexane, 1:8) to give 513 mg (62%)
of compound 8 as a yellow oil; Rf ¼ 0.45 (SiO2, EtOAc/hex-
ane, 1:8); 1H NMR (300 MHz, CDCl3) d 7.18 (s, 2H), 3.70–
3.58 (m, 1H), 3.41–3.28 (m, 2H), 2.22–1.96 (m, 6H), 1.56–
1.16 (m, 11H), 0.94–0.78 (m, 6H); 13C NMR (75 MHz, CDCl3)
d 157.4, 157.2, 136.1, 136.0, 119.1, 119.0, 107.2, 74.7, 71.3,
40.3, 30.9, 29.6, 29.5, 29.0, 24.2, 23.3, 14.4, 11.4; HRMS, m/e
calcd for C20H28Br2N2O 470.0568, measured 470.0566.
Synthesis of 4,7-Di(thien-20-yl)-2H-benzimidazole-
2-spiro-400-[(2000-ethylhexyl)oxy]-cyclohexane (12)
To a stirred solution of 4,7-dibromo-40-[(2-ethylhexyl)oxy]-
2H-benzimidazole-2-spirocyclohexane (965 mg, 2.04 mmol)
(8) and 4,4,5,5-tetramethyl-2-(20-thienyl)-1,3,2-dioxaborolane
(2.15 g, 10.21 mmol) (9) in toluene (15 mL) under argon
was added tetrakis(triphenylphosphine) palladium(0) (236
mg, 0.20 mmol) and degassed 2 M K2CO3 (aq) (10.21 mL).
After being stirred at 80 ꢂC for 12 h, the reaction mixture
was diluted with ethyl acetate (100 mL), washed with
distilled water (3 ꢃ 100 mL), and dried (MgSO4). After
removing the solvent under reduced pressure, the residue
was purified by flash chromatography (40 ꢃ 150 mm col-
umn, SiO2, CH2Cl2/hexane, 1:1) to give 0.82 g (84%) of com-
pound 12 as a red oil; Rf ¼ 0.4 (SiO2, CH2Cl2/hexane, 1:1);
1H NMR (300 MHz, CDCl3) d 8.15 (dd, 1H, J ¼ 3.85,
4.95 Hz), 8.06 (dd, 1H, J ¼ 3.85, 4.95 Hz), 7.40–7.34 (m, 2H),
7.31 (s, 2H), 7.16–7.10 (m, 2H), 3.76–3.65 (m, 1H), 3.52–
3.39 (m, 2H), 3.32–2.10 (m, 5H), 1.66–1.28 (m, 12H), 0.95 (t,
6H, J ¼ 7.42 Hz); 13C NMR (75 MHz, CDCl3) d 158.2, 158.1,
139.0, 139.0, 128.9, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2,
128.0, 126.9, 126.8, 107.6, 76.0, 71.6, 40.2, 30.9, 30.4, 30.2,
29.4, 24.2, 23.4, 14.4, 11.4; HRMS, m/e calcd for
Synthesis of 4,7-Di(thien-20-yl)-2H-benzimidazole-
2-spirocyclohexane (10)
To a stirred solution of 4,7-dibromo-2H-benzimidazole-2-spi-
rocyclohexane (4.2 g, 12.21 mmol) (4) and 4,4,5,5-tetra-
methyl-2-(20-thienyl)-1,3,2-dioxaborolane (8.98 g, 42.73
mmol) (9) in toluene (42 mL) under argon was added tetra-
kis(triphenylphosphine) palladium(0) (1.41 g, 1.22 mmol)
and degassed 2 M K2CO3 (aq) (61.04 mL). After being stirred
at 80 ꢂC for 12 h, the reaction mixture was diluted with
ethyl acetate (100 ml), washed with distilled water (3 ꢃ 100
mL), and dried (MgSO4). After removing the solvent under
reduced pressure, the residue was purified by flash chroma-
tography (40 ꢃ 150 mm column, SiO2, CH2Cl2/hexane, 1:1)
to give 2.15 g (50%) of compound 10 as a red solid; Rf ¼
0.4 (SiO2, CH2Cl2/hexane, 1:1); 1H NMR (300 MHz, CDCl3) d
C28H34N2OS2 478.2113, measured 478.2109.
Synthesis of 4,7-Di(20-bromothien-50-yl)-2H-benzimidazole-
2-spiro-400-[(2000-ethylhexyl)oxy]-cyclohexane (13)
To a stirred solution of 4,7-di(thien-20-yl)-2H-benzimidazole-
2-spiro-400-[(2000-ethylhexyl)oxy]-cyclohexane (711 mg, 1.49
mmol) (12) in CHCl3 (18 mL) protected from light under
argon was added NBS (449 mg, 2.52 mmol). After being
stirred at room temperature for 3 h, the reaction mixture
was diluted with CHCl3 (100 mL), washed with saline (3 ꢃ
372
WILEYONLINELIBRARY.COM/JOURNAL/JPOLA